2. Case report
In April 2015, a 65-year-old female patient sought care at Purpose Driven Dental Clinic, reporting discomfort with her old upper and lower removable dentures. Examination revealed severely atrophic upper and lower edentulous ridges, save for three remaining teeth (right upper canine, right upper incisor, and left lower canine). Panoramic X-ray imaging indicated that the residual crestal bone height in the first molar area above the upper border of the inferior mandibular canal was 2.2 mm on the right side and 4.0 mm on the left side. The patient expressed her desire for replacing the edentulous areas with fixed prostheses using dental implants.
While dental implant placement was feasible in some upper posterior molar crestal areas without notable challenges, the lower posterior regions lacked sufficient crestal bone for implantation without significant bone augmentation.
Figure 1.
The initial intraoral photos showed that the upper arch had only two teeth remaining, both with root caries and periapical abscesses, while the other teeth were missing. The lower arch displayed severely atrophic mandibular edentulous ridges, with only the left canine remaining. Please note that the residual crest of the right edentulous ridge is flush with the level of the mouth floor.
Figure 1.
The initial intraoral photos showed that the upper arch had only two teeth remaining, both with root caries and periapical abscesses, while the other teeth were missing. The lower arch displayed severely atrophic mandibular edentulous ridges, with only the left canine remaining. Please note that the residual crest of the right edentulous ridge is flush with the level of the mouth floor.
Given this requirement, a preparatory bone augmentation procedure was determined to be necessary. However, the soft tissue covering the crestal bone was too scant for effective vertical bone augmentation. Addressing this issue, a Soft Tissue Expansion procedure was undertaken prior to the bone augmentation using a Self-Inflating Tissue Expander (SITE) (Osmed.com).
Figure 2.
On 28th May 2015, a small incision was made in the right posterior edentulous site of the mandible, through which a Self-Inflating Tissue Expander (SITE) was inserted into a subperiosteal pouch and subsequently sutured.
Figure 2.
On 28th May 2015, a small incision was made in the right posterior edentulous site of the mandible, through which a Self-Inflating Tissue Expander (SITE) was inserted into a subperiosteal pouch and subsequently sutured.
On May 28, 2015, a 1.3 ml SITE (Self-Inflating Tissue Expander, manufactured by Osmed in Germany) device was inserted into the right edentulous ridge through a small pouch created by a 4 mm stab incision. Subsequently, on June 2, 2015, a similar procedure was performed on the left edentulous ridge using the same technique and a 1.3 ml SITE device (manufactured by Osmed in Germany).
On June 2, 2015, wound dehiscence occurred at the insertion site of the SITE on the right side, necessitating the removal of the SITE. Consequently, a new 0.7 ml SITE was inserted on September 9, 2015.
Figure 3.
On 1st June 2015, the same procedure was performed at the left posterior edentulous site of the mandible. Please note the use of a before-and-after template for predicting the final result.
Figure 3.
On 1st June 2015, the same procedure was performed at the left posterior edentulous site of the mandible. Please note the use of a before-and-after template for predicting the final result.
The SITEs were removed after achieving full expansion, in adherence to the manufacturer's recommendations—50 days later on the left side and 37 days later on the right side. The vertical bone augmentation procedures were conducted simultaneously. Xenograft material (Bio-Oss, produced by Geistlich in Switzerland) was utilized for the augmentation and covered with a Goretex titanium-reinforced membrane (made in the USA) through the same small openings used for the SITEs removal. The incisions were sutured with 4-0 Monocryl, and the stitches were removed two weeks later, revealing no significant wound dehiscence.
Figure 4.
Bone graft procedures were performed when the SITEs were removed after their full expansion. The GBR technique was used with xenograft (Bio-Oss large granule) and Gore-Tex TR membrane. The same small incisions used for removing SITEs on both sides were sufficient for GBR, thanks to the prior soft tissue expansion. The procedures were carried out on different dates for each side, with the left side being treated on August 25, 2015, and the right side on October 16, 2015.
Figure 4.
Bone graft procedures were performed when the SITEs were removed after their full expansion. The GBR technique was used with xenograft (Bio-Oss large granule) and Gore-Tex TR membrane. The same small incisions used for removing SITEs on both sides were sufficient for GBR, thanks to the prior soft tissue expansion. The procedures were carried out on different dates for each side, with the left side being treated on August 25, 2015, and the right side on October 16, 2015.
On June 3, 2015, in the lower anterior area, implants were placed at the sites of both lateral incisors, measuring 3.6 x 10 mm and 3.6 x 11 mm respectively, using Oneplant Warrentec implants manufactured in Korea. Concurrently, a bone graft was performed using the guided bone regeneration (GBR) technique, involving a collagen membrane from ACE Surgical Supply Co., USA, and a xenograft from Bio-Oss, Geistlich, Switzerland, though without the use of a Self-Inflating Tissue Expander (SITE). Importantly, the restoration of this area was completed prior to initiating the implant surgery in the posterior areas.
Following an 8-month period for bone consolidation, implants were then placed in the left lower posterior edentulous areas on April 18, 2016. A 4.5 x 9 mm OsseoSpeed TX implant from Astratec, Germany, was used for the first premolar, and 4.3 x 7 mm and 4.8 x 8 mm Oneplant implants from Warrentec, Korea, were used for the second premolar and the first molar, respectively. Additionally, a 4.0 x 6.0 mm OsseoSpeed TX implant, also from Astratec, Germany, was placed.
Seven months following the first bone graft, performed on the day the SITE was removed from the right posterior area of the mandible, 5 x 9 mm OsseoSpeed TX implants (Astratec, manufactured in Germany) were placed for the first premolar and the canine. However, the procedure to place implants in the molar area was deferred; instead, a second bone graft utilizing the GBR technique was conducted to augment the bone volume, ensuring it could accommodate implants of the appropriate size.
Figure 5.
After an 8-month waiting period for bone consolidation, implants were placed in the left posterior area following the removal of the Gore-Tex membrane. It is noteworthy to mention the well-matured bone achieved from the bone graft procedure. Photographs documenting this progression include one from the left side on April 1, 2016, the day the left natural canine crown was set; April 18, 2016, the day of the operation on the left posterior area of the mandible; and two images from the right side on October 26, 2016, the day of implant placements for the right second premolar and the right first molar, 6 months after the second bone graft.
Figure 5.
After an 8-month waiting period for bone consolidation, implants were placed in the left posterior area following the removal of the Gore-Tex membrane. It is noteworthy to mention the well-matured bone achieved from the bone graft procedure. Photographs documenting this progression include one from the left side on April 1, 2016, the day the left natural canine crown was set; April 18, 2016, the day of the operation on the left posterior area of the mandible; and two images from the right side on October 26, 2016, the day of implant placements for the right second premolar and the right first molar, 6 months after the second bone graft.
In the upper jaw, implants (Oneplant Warrentec, manufactured in Korea) were inserted using standard techniques, selecting the most advantageous sites for implant placement for the patient's convenience. The final fixed prosthodontics consisted of five pieces: an anterior piece spanning from the right premolar to the left premolar, both second premolars, and a two-unit posterior molar bridge on each side. All implant prostheses were cemented with ready-made stock abutments extraorally and secured by screw tightening, completing all procedures on January 27, 2016.
Figure 6.
The fixed restorations with implants for the upper arch were completed more simply than those for the lower arch because the existing bone had sufficient quantity to support the implants. The prostheses were divided into five pieces: one anterior bridge, two premolar single crowns, and two bridges for the molar areas. To simplify the procedure and facilitate ease, the most favorable sites were selected for anterior implant placement. Please note the path for inserting the anterior implants, which includes one path extraorally after cementation.
Figure 6.
The fixed restorations with implants for the upper arch were completed more simply than those for the lower arch because the existing bone had sufficient quantity to support the implants. The prostheses were divided into five pieces: one anterior bridge, two premolar single crowns, and two bridges for the molar areas. To simplify the procedure and facilitate ease, the most favorable sites were selected for anterior implant placement. Please note the path for inserting the anterior implants, which includes one path extraorally after cementation.
The implant restorations for the lower left posterior area were finalized on September 28, 2016, five months following the implant placements. Subsequently, the restorations for the lower right canine and first premolar were completed on December 23, 2016, seven months post-implantation. The final restorations for the lower right first molar and second molar were accomplished on May 2, 2017, six months after their implantation. This marked the conclusion of all fixed prosthesis work, spanning a total of 23 months from the beginning to the end of the treatment process.
Figure 7.
On May 4, 2017, the fixed restorations with implants for the lower arch were completed, 23 months after the commencement of the procedure, through vertical bone grafting via SITE. The completion on the right side was delayed compared to the left side due to the need for more bone regeneration, although both sides underwent the same procedure. Please compare the before-and-after treatment pictures.
Figure 7.
On May 4, 2017, the fixed restorations with implants for the lower arch were completed, 23 months after the commencement of the procedure, through vertical bone grafting via SITE. The completion on the right side was delayed compared to the left side due to the need for more bone regeneration, although both sides underwent the same procedure. Please compare the before-and-after treatment pictures.
Throughout all procedures, the patient tolerated the treatments well, experiencing no surgical complications such as nerve injury or wound infection. She used temporary removable dentures; however, during the critical postoperative period, she was advised against wearing them to avoid surgical complications from potential trauma. The patient's chewing ability was effectively restored, with occlusion being verified using Shimstock. The graft bone demonstrated stable results, showing no signs of inflammation or resorption. The implants were functioning well, with no mobility or pain reported. The patient expressed satisfaction with the outcome.
Figure 8.
After 5 months, on October 24th, 2017, a follow-up visit confirmed the success of the treatments. The soft tissue displayed healthy architecture without compromising the vestibular depth. The proportion between the crown height and the mucosal portion appeared natural. Notably, there were no soft tissue complications, such as bleeding, swelling, or erythema. From the frontal view, the overall appearance was deemed acceptable.
Figure 8.
After 5 months, on October 24th, 2017, a follow-up visit confirmed the success of the treatments. The soft tissue displayed healthy architecture without compromising the vestibular depth. The proportion between the crown height and the mucosal portion appeared natural. Notably, there were no soft tissue complications, such as bleeding, swelling, or erythema. From the frontal view, the overall appearance was deemed acceptable.
During the follow-up period extending to 2024, a minor prosthetic complication occurred: the upper anterior bridge became detached due to the failure of the dental cement, resulting in a loss of retention between the bridge and the implant abutment. Additionally, a small fracture was noted in a portion of the marginal area, characterized by chipping. The patient opted against the fabrication of a new bridge, preferring instead to have the existing anterior bridge re-cemented. This repair was straightforward and did not necessitate the creation of a new prosthetic.
Except for this event, there have been no other complications in both biological and mechanical aspects. This means there have been neither peri-implant mucositis nor peri-implantitis, and there have been no prosthodontic complications.
The patient's masticatory function has been almost fully restored, without any discomfort or difficulties during eating. Her appearance looks natural, as though she had her natural teeth, even though she does not.
Figure 9.
The lower pictures were taken on May 2, 2023, and January 9, 2024, each six years and seven years after the final finishing, respectively. Please compare them with the initial pictures taken before treatment. The rehabilitation using SITE has shown stable results throughout the follow-up period.
Figure 9.
The lower pictures were taken on May 2, 2023, and January 9, 2024, each six years and seven years after the final finishing, respectively. Please compare them with the initial pictures taken before treatment. The rehabilitation using SITE has shown stable results throughout the follow-up period.
3. Results
Vertical bone changes at the right operation site were evaluated before surgery and then annually post-surgery for comparison. Measurements were taken from the superior border of the inferior alveolar canal to the crest of the ridge at two designated points: Point A, the lowest part of the edentulous ridge at baseline, and Point B, positioned above the mental foramen. To ensure measurement consistency, the length of the right upper second molar implant was used as a calibration standard. Prior to these measurements, to ascertain the repeatability of the points A and B assessments, the rectangular distance from the inferior border of the inferior alveolar canal to the bottom border of the mandible was verified.
Initially, in April 2015, the heights at Points A and B were recorded as 1.3 mm and 2.5 mm, respectively. Subsequent to the first bone graft, facilitated by SITE (Self Inflating Tissue Expander), the heights increased to 7.1 mm at Point A and 7.6 mm at Point B by October 2015, resulting in vertical increments of 5.8 mm at Point A and 5.1 mm at Point B. Following the second bone graft, minor increases were observed in May 2016, with heights reaching 8.9 mm at Point A and 9.7 mm at Point B. By the day of implant prosthesis completion in May 2017, both Points A and B recorded a crestal height of 8.3 mm. These heights were then tracked annually, showing a marginal decrease of 0.1 mm from the prosthesis completion in May 2017 to 2023. Over a span of six years, the overall decreases were 1.1 mm at Point A and 0.7 mm at Point B, deeming these results indicative of stable crestal bone changes.
Figure 10.
This graph illustrates the vertical bone changes at the right operation site, detailing measurements from Point A—the baseline's lowest part of the edentulous ridge—and Point B, which is located above the mental foramen.
Figure 10.
This graph illustrates the vertical bone changes at the right operation site, detailing measurements from Point A—the baseline's lowest part of the edentulous ridge—and Point B, which is located above the mental foramen.
Table 2.
showing a comprehensive overview of the crestal height changes at Points A and B from the initial measurement in April 2015, through the interventions and up to the most recent check in June 2023. The notes column provides additional context to the measurements, highlighting the significant gains after the grafts and the slight annual decreases post-implant completion, which have been deemed stable.
Table 2.
showing a comprehensive overview of the crestal height changes at Points A and B from the initial measurement in April 2015, through the interventions and up to the most recent check in June 2023. The notes column provides additional context to the measurements, highlighting the significant gains after the grafts and the slight annual decreases post-implant completion, which have been deemed stable.
Time |
Point A Height (mm) |
Point B Height (mm) |
Notes |
Apr 2015 |
1.3 |
2.5 |
Initial Measurements |
Oct 2015 |
7.1 |
7.6 |
After 1st Bone Graft (Vertical Gains: 5.8mm & 5.1mm for A & B) |
May 2016 |
8.9 |
9.7 |
After 2nd Bone Graft (Increases: 1.8mm & 2.1mm for A & B) |
Oct 2016 |
8.4 |
8.7 |
Adjustment Post-2nd Graft |
May 2017 |
8.3 |
8.3 |
At Completion of Implant Prostheses |
Apr 2018 |
8.2 |
7.8 |
Annual Check |
June 2020 |
7.6 |
7.5 |
Annual Check |
Dec 2022 |
7.3 |
7.7 |
Annual Check |
June 2024 |
7.2 |
7.6 |
Latest Measurement (Total Reductions: 1.1mm & 0.7mm for A & B over 6 years) |
Figure 11.
Panoramic X-ray images displaying the perioperative state along with the annual changes postoperatively.
Figure 11.
Panoramic X-ray images displaying the perioperative state along with the annual changes postoperatively.
Figure 12.
illustrating the horizontal width measurements at the crestal level, showing 8.9 mm at Point A and 9.2 mm at Point B. Further down, at the middle level, the measurements increased to 10.1 mm and 11.9 mm, respectively, demonstrating a sufficient bone width necessary for implant support.
Figure 12.
illustrating the horizontal width measurements at the crestal level, showing 8.9 mm at Point A and 9.2 mm at Point B. Further down, at the middle level, the measurements increased to 10.1 mm and 11.9 mm, respectively, demonstrating a sufficient bone width necessary for implant support.
4. Discussion
Bone grafting has emerged as a cornerstone in the rehabilitation of oral tissues lost to various causes, including teeth, bone, and the surrounding soft tissues, through dental implantation [
8,
9]. The loss of teeth invariably leads to the concurrent loss of interdependent tissues, underscoring the complexity of oral rehabilitation [
10]. Although implant dentistry primarily aims to restore chewing function, it also encompasses the regeneration of all missing oral tissues, regardless of their immediate contribution to functional improvement.
Bone grafting is crucial for implantation under two primary circumstances. Firstly, it is necessary when the available sites for implantation lack sufficient volume to support the smallest implant sizes, rendering the restoration unfeasible without further augmentation [
3]. Secondly, aesthetic considerations and the aim for lasting stability come into play, notably in restoring anterior teeth. This approach is equally important for posterior teeth restorations [
9]. For example, a clinical crown that is excessively long compared to adjacent teeth may look unnatural. Additionally, an optimal bone phenotype around the implants, characterized by a proper bone thickness, plays a vital role in maintaining their biological stability over time. Both circumstances, alongside the established understanding that tooth loss inevitably leads to the simultaneous loss of bone and soft tissues, highlight the fundamental importance of bone grafting in implant dentistry.
A broad spectrum of techniques is employed in bone grafting for dental implants, designed to tackle the varied clinical scenarios encountered in patient care. These procedures can be categorized based on the recipient site's topography into two main types: grafts for internal contained defects and grafts for external augmentation. The former includes methods such as socket preservation and sinus grafts, which are directed at repairing deficits within the bone structure. Meanwhile, external augmentation often incorporates a soft tissue releasing procedure integral to the bone grafting process itself, underlining the diversity and complexity of approaches needed to satisfy the comprehensive range of anatomical and aesthetic requirements. However, the pivotal element in external augmentation lies in flap management, which includes soft tissue expansion to ensure primary closure and prevent wound dehiscence, further emphasizing the critical role of meticulous soft tissue handling in the success of these procedures [
11].
From this perspective, the soft tissue expander was conceived. Throughout the development process for the right device, Osmed company introduced the Self-Inflating Tissue Expander (SITE), a notable innovation in this field. The Osmed tissue expander is made of a hydrogel material. Hydrogels are highly absorbent polymers that can retain a significant amount of water or biological fluids, swelling to several times their original size. This property allows the Osmed tissue expanders to gradually expand as they absorb bodily fluids, thereby stretching the surrounding tissues over time. The specific composition of the hydrogel used in Osmed tissue expanders is designed to ensure biocompatibility, optimal expansion rates, and sufficient mechanical strength to meet the requirements of the intended medical or dental applications [
5,
6,
7].
If the required volume for external bone augmentation for implant placement is moderate or less, the bone grafting can be performed with conventional techniques, accompanied by soft tissue releasing. However, cases that demand a significantly larger volume for augmentation pose considerably greater challenges [
11,
12].
While other alternative techniques could have been considered [
13], the author opted to utilize the Self-Inflating Tissue Expander (SITE) for the case presented.
The upper arch (full edentulous arch) was successfully restored using standard dental implant procedures without any significant issues. However, a specific treatment plan was devised for the upper side, focusing on selecting the optimal locations for implant placement to achieve the desired outcomes more easily and efficiently. Thus, for the anterior part of the upper arch, the sites for both first premolars and the left incisor were chosen for an 8-unit implant bridge. The implants were positioned in parallel to ensure that the prosthesis could be securely attached by screwing it in place after extraoral cementation, with the margins positioned subgingivally to fulfill aesthetic requirements.
The lower arch, which was fully edentulous except for the left canine, was segmented into four parts to facilitate the surgical process in stages.
The right and left posterior edentulous ridges were severely atrophic, resulting in a minimal distance between the ridge crest and the inferior alveolar canal, alongside a very narrow crest width. Consequently, the majority of the alveolar bone needed for implant placement had to be regenerated through bone grafting to ensure successful outcomes. This was particularly critical for the right posterior ridge, where virtually no bone was available for implant treatment. Initially, the distance measured 1.5 mm at Point A and 2.3 mm at Point B, with Point A representing the lowest part of the edentulous ridge at baseline and Point B located above the mental foramen. Ultimately, as detailed earlier in this report's case study, the bone grafting procedure using the Self-Inflating Tissue Expander (SITE) proved successful for implant placement. The maximum amount of vertical bone gain achieved was 7.6 mm at Point A and 7.2 mm at Point B.
The horizontal width measurements at the crestal level showed 8.9 mm at Point A and 9.2 mm at Point B. Deeper, at the middle level, the measurements increased to 10.1 mm and 11.9 mm, respectively, indicating a substantial growth in bone width crucial for implant support. The peak horizontal bone augmentation reached was 11.9 mm, signifying notable enhancements in the dimensions vital for successful implant placement.
The final outcome with the implant prostheses was realized in May 2017, after nearly two years of treatment from the onset. The patient has undergone annual follow-ups since completion. Crestal bone loss has been recorded at a rate of 0.1 mm per year, which is deemed stable [
14]. Throughout this period, there have been no specific events or complications related to the implants, either surgically or prosthodontically. For the left side, similarly excellent results have been observed, with no more than 0.5 mm of bone loss recorded up to 2024 since the treatment's completion.
Upon deeming the bone graft procedure successful, the following claim is substantiated: After achieving pre-surgical objectives and ensuring stable outcomes from bone grafts, it's vital to recognize that the determinants of implants' long-term success do not differ, regardless of bone grafting. These determinants, affecting both the biological and mechanical integrity of implants, can lead to issues like peri-implantitis and mechanical problems such as abutment fractures, impacting implant performance equally in grafted and non-grafted situations. Thus, the use of a bone graft does not modify the risk factors for peri-implantitis [
15,
16].
Concerning the selection of graft material, Bio-Oss xenograft from Geistlich Pharma was exclusively utilized [
17,
18,
19]. The outcomes of this report confirm that the graft material’s function, acting solely as a scaffold, is effectively achieved, facilitating the regeneration of new bone as long as space is maintained for the bone to form [
20]. Notably, this space was established using the SITE method, avoiding typical surgical complications such as wound dehiscence.